Public Health England releases updates on VTEC, Ebola, pertussis vaccinations and cyclospora

Public Health England (PHE) released a Public Health Report update on Friday about several health concerns including a verocytotoxigenic Escherichia coli (VTEC) outbreak, prenatal pertussis vaccine coverage, Ebola virus disease (EVD) and cyclospora. Read More »

VBI Vaccines receives grant to advance RSV candidate

VBI Vaccines Inc. recently received approximately $265,000 in grants to further develop the company’s eVLP Platform, which will be used to create a respiratory syncytial virus (RSV) vaccine candidate. Read More »

First patient receives Inovio's universal HIV vaccine

Clinical trial for PENNVAX-GP meant to determine tolerability and safety of vaccine. Read More »

Medidata technology to aid Walvax pediatric vaccine program in China

Medidata, a leading provider of cloud-based solutions for clinical research in life sciences, said Tuesday that Walvax Biotechnology Co., Ltd., a biopharmaceutical company based in China, recently adopted its cloud-based platform to further advance China’s pediatric vaccine program. Read More »

Mobile phone records may predict dengue fever epidemics

Harvard T.H. Chan School of Public Health said Monday that its researchers found that mobile phone records may be useful in predicting and timing the geographical spread of dengue fever epidemics. Read More »

Study hints at new pathway for MRSA vaccine

NYU Langone Medical Center announced Wednesday that its research recently found a possible new pathway to developing a vaccine for Staphylococcus aureus, commonly called HA-MRSA. Read More »

Malawi study shows HIV self-testing is acceptable, safe and accurate

Researchers recommend widespread use of self-testing in sub-Saharan Africa's urban settings. Read More »

China finalizes support of immunization in developing nations

The Chinese government recently made a formal commitment to offer $5 million to support Gavi, which is the Vaccine Alliance that helps to fund childhood immunizations in the poorest nations around the world. Read More »

Flu vaccines decrease deaths and hospitalizations of nursing home residents

Analysts involved in a study that included over 1 million Medicare fee-for-service long-stay residents at various nursing homes have shown that these residents have decreased statistics of hospitalizations and deaths when they receive the influenza vaccine. Read More »

Doctors Without Borders tries to ward off measles outbreak in Congo

The measles epidemic in Congo's Katanga province must be halted in fewer than 60 days to prevent a major health crisis, according to Doctors Without Borders.  Read More »

Novavax RSV F vaccine trial for women shows promise

Clinical trial subjects show improved immune system response after receiving vaccine. Read More »

Forest Service unlikely contributor to study of Ebola virus in Liberia

A study recently conducted by United States Forest Service researchers shows that social vulnerability indices typically used for natural hazards and climate change research can be helpful with disease outbreaks. Read More »

Calif. tells health care providers to be on the lookout for measles

Warning comes after earlier outbreak that started at Disneyland. Read More »

Economic analysis of higher-dose and standard-dose influenza vaccine for elderly

The Lancet Infectious Diseases recently published a new economic analysis comparing higher-dose influenza vaccines with standard-dose influenza vaccines among senior citizens. Read More »

Higher flu vaccine rates among adults linked to reduced flu risk for seniors

A recent study shows that when healthy adults receive the flu vaccine, they protect themselves as well as elderly adults living in their communities from higher risks of developing serious health complications due to influenza. Read More »

IOM proactively prevents illness at South Sudan displacement sites

International Organization for Migration health teams have been encouraging people living in displacement sites in South Sudan to practice preventive health care to avoid the spread of diseases. These measures include two cholera vaccination campaigns. Read More »

Study shows Ebola mutations can evade antibiotic treatments

The deadly Ebola virus has genetic mutations, or “escape variants,” that evade antibody-based treatments designed to fight infection. Read More »

New Ebola test may help stop epidemic in West Africa

Scientists from the Chinese Academy of Sciences recently created an innovative Ebola test that may help stop the spread of the Ebola virus throughout West Africa. Read More »

European health officials review response to current HIV epidemic

The European Centre for Disease Prevention and Control (ECDC) recently published a report that explains how countries in Europe have responded to the current HIV epidemic that started in 2004. Read More »

Agenus Inc. finalizes transaction terms with Oberland Capital

Agenus Inc., an immunology company that discovers and creates novel treatments for diseases like cancer, recently announced that it has finalized its non-dilutive royalty transactions pursuant to a note purchase agreement with Oberland Capital Management LLC, the leader of the investor group. Read More »